N/A N=90 Randomized Single-blind Treatment

Feasibility Study on the Impact of Economic Incentives to Improve the Management of Type 2 Diabetes Mellitus

Diabetes Mellitus, Type 2

Bottom Line

View on ClinicalTrials.gov: NCT02891382 ↗

Enrolled (actual)

Serious AEs

0.0%

Results posted

Feb 2024

Primary outcome: Primary: Change in Glycated Hemoglobin — 1.4; 0.9; 1.1 "Percentage of glycated hemoglobin"

Study Design & Population

Study type: Interventional
Phase: N/A
Interventions: Diabetes education (Behavioral); Goal setting (Behavioral); Companion Support (Behavioral); Individual Reward (Behavioral); Shared Reward (Behavioral)
Age: Adult, Older Adult · 18+ yrs
Sex: All
Sponsor: Universidad Peruana Cayetano Heredia
Primary completion: Feb 2017

Outcome Measures

Outcome	Result	p-value
PRIMARY Change in Glycated Hemoglobin	1.4; 0.9; 1.1	—
SECONDARY Change in Weight	2.9; 0.4; 0.4	—

Summary

This feasibility study aims to compare the implementation process of three different interventions that use economic incentives to promote lifestyle behavioral changes in patients with type 2 diabetes mellitus, and to identify barriers and facilitators linked to the process of implementing each of the interventions. The interventions are based on economic incentives directed to the patient (individual incentives) or a team comprised by the patient and a partner (mixed incentives). Design: Three-month randomized control feasibility study to test the feasibility of implementing three types of intervention with economic incentives in patients with diabetes mellitus. Setting: Diabetes outpatient clinics from a public hospital in Peru.

Eligibility Criteria

Inclusion criteria for participants:

Type 2 diabetes mellitus
Body mass index 25-39.9 kg/m2, irrespective of HbA1c status
Able to give consent

Exclusion Criteria for participants:

Diagnosis of cancer or another serious comorbidity
Pharmacotherapy for weight loss or corticosteroids
Pregnant women
Blindness, amputation, foot ulcer or being on dialysis
Be companion/team support for another participant in the trial

Inclusion criteria for the companion/team support:

Available and committed to supporting the participant in achieving their goals
Able to provide consent

Exclusion criteria for the companion/team support:

Physical or mental condition that does not allow him to help the participant to achieve goals

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT02891382). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.